01 / Contract Profile
75N93023C00001 Federal Contract Award
Agency code 7529
EO14398 TO DEVELOP THE PPZ SERIES OF SMALL MOLECULE PAN-FILOVIRUS ENTRY INHIBITORS THROUGH LEAD OPTIMIZATION, SELECTION OF A PRECLINICAL CANDIDATE, AND IND-ENABLING PRECLINICAL STUDIES.
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
75N93023C00001 contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations$3.79M
FY 2026Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2022 | $2.07M | 1 | — |
| FY 2023 | $0 | 1 | −100.0% |
| FY 2024 | $0 | 1 | — |
| FY 2025 | $2.94M | 1 | — |
| FY 2026 | $3.79M | 2 | +28.9% |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH | NATIONAL INSTITUTES OF HEALTH NIAID |
05 / Contractor
Who holds this federal contract?
MICROBIOTIX, INC.
UEI SCNKBDM341T1 · CAGE 465F8
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | $8.80M | 6 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| AN12 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH | $8.80M | 6 | 100.0% |
08 / Place of Performance
Where is the work recorded?
WORCESTER, WORCESTER, MASSACHUSETTS, UNITED STATES
ZIP 016054307
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Aug 21, 2026 | P00005 | $3.79M | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541715 | AN12 |
| Jul 9, 2026 | P00004 | $0 | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541715 | AN12 |
| Aug 19, 2025 | P00003 | $2.94M | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541715 | AN12 |
| Oct 10, 2024 | P00002 | $0 | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541715 | AN12 |
| Sep 26, 2023 | P00001 | $0 | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541715 | AN12 |
| Oct 31, 2022 | Base action | $2.07M | NATIONAL INSTITUTES OF HEALTH NIAIDOffice code 75N930 | 541715 | AN12 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.